Select Bibliography

Filter by any of these (after searching):

Wang, Xiaofei

There are 56 items

Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503)

Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - - Lancet Respir Med - 2018

Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0010

Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503)

Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - AATS - - 2018

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-140503

Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance)

Augert, Arnaud , Zhang, Qing , Bates, Breanna , Cui, Min ... - - J Thorac Oncol - 2017

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-151111

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

Baggstrom, Maria Q. , Socinski, Mark A. , Wang, Xiaofei F. , Gu, Lin ... - - J Thorac Oncol - 2017

Manuscript - Primary - Primary - Respiratory - CALGB-30607 , CALGB-70701

Phase I Study of Accelerated Conformal Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Patients With Pulmonary Dysfunction: CALGB 39904

Bogart, Jeffrey A. , Hodgson, Lydia , Seagren, Stephen L. ... - - J Clin Oncol - 2010

Manuscript - Primary - Primary - Respiratory - CALGB-39904

Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on the experimental thoracic radiotherapy (TRT) arms of CALGB 30610 (Alliance) / RTOG 0538

Bogart, Jeffrey , Wang, Xiaofei , Masters, Gregory , Zhu, Han ... - ESMO - Ann Oncol - 2019

Abstract - Secondary - Primary - Respiratory - CALGB-30610

Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non-small cell lung cancer; Results from CALGB 159902

Boylan, Alice M. , Wang, Xiaofei F , Ko, Richard , Watson, Patricia M ... - - J. Thorac. Cardiovasc. Surg. - 2013

Manuscript - Secondary - Primary - Respiratory - CALGB-159902

Multi-institutional prospective validation of prognostic mRNA signatures in early stage squamous lung cancer (Alliance).

Bueno, Raphael , Richards, William G , Harpole, David H ... - - J Thorac Oncol - 2020

Manuscript - Primary - Meta-Analysis - Correl Sci NOS - CALGB-150807 , CALGB-140202

Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)

Demmy, Todd L. , Gu, Lin , Burkhalter, Jack E. , Toloza, Eric M. ... - - J Natl Compr Canc Netw - 2012

Manuscript - Primary - Primary - Respiratory - CALGB-30102

A phase II study of sorafenib in malignant mesothelioma: results of CALGB 30307

Dubey, Sarita , Jänne, Pasi A. , Krug, Lee , Pang, Herbert ... - - J Thorac Oncol - 2010

Manuscript - Primary - Primary - Respiratory - CALGB-30307

Randomized phase 2 study of maintenance pemetrexed versus observation for patients (pts) with malignant pleural mesothelioma (MPM) without progression after first-line chemotherapy: Cancer and Leukemia Group B (CALGB/Alliance) 30901

Dudek, Arkadiusz Z. , Wang, Xiaofei , Gu, Lin , Stinchcombe, Thomas ... - ASCO - J Clin Oncol - 2019

Abstract - Primary - Primary - Respiratory - CALGB-30901

Randomized Study of Maintenance Pemetrexed Versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901.

Dudek, Arkadiusz Z , Wang, Xiaofei , Gu, Lin , Duong, Stephanie ... - - Clin Lung Cancer - 2020

Manuscript - Primary - Primary - Respiratory - CALGB-30901

CYFRA 21-1 as a prognostic and predictive marker in advanced non-small cell lung cancer in a prospective trial: CALGB 150304

Edelman, Martin J. , Hodgson, Lydia , Rosenblatt, Paula Y. ... - - J Thorac Oncol - 2012

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150304

Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304

Edelman, Martin J. , Hodgson, Lydia , Wang, Xiaofei ... - - J Thorac Oncol - 2011

Manuscript - Secondary - Primary - Respiratory - CALGB-150304 , CALGB-30203

Final Results of a phase III trial of celecoxib (C) in addition to standard chemotherapy for advanced NSCLC with COX- 2 overexpression: CALGB 30801 (Alliance)

Edelman, Martin J. , Wang, Xiaofei , Hodgson, Lydia ... - MSTO - Int. J. Radiat. Oncol. Biol. Phys. - 2017

Abstract - Primary - Primary - Respiratory - CALGB-30801

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)

Edelman, Martin J. , Wang, Xiaofei , Hodgson, Lydia ... - - J. Clin. Oncol - 2017

Manuscript - Primary - Primary - Respiratory - CALGB-30801

Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.

Edelman, Martin J , Watson, Dee , Wang, Xiaofei , Morrison, Carl ... - - J. Clin. Oncol. - 2008

Manuscript - Primary - Primary - Respiratory - CALGB-30203

Multi-Trial Evaluation of Progression-Free Survival (PFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Foster, Nathan R. , Renfro, Lindsay A. , Schild, Steven E. ... - - J Thorac Oncol - 2015

Manuscript - Secondary-not-in-original - Meta-Analysis - Respiratory - CALGB-30103 , N0424 , NCCTG-932053

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407

Govindan, Ramaswamy , Bogart, Jeffrey , Stinchcombe, Thomas ... - - J Clin Oncol - 2011

Manuscript - Primary - Primary - Respiratory - CALGB-30407

A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.

Govindan, Ramaswamy , Wang, Xiaofei , Baggstrom, Maria Q ... - - J Thorac Oncol - 2009

Manuscript - Primary - Primary - Respiratory - CALGB-30104

Prognostic Significance of Mucin and p53 Expression in Stage IB Non-Small Cell Lung Cancer: A Laboratory Companion Study to CALGB 9633

Graziano, Stephen L. , Gu, Lin , Wang, Xiaofei , Tatum, Arthur H. ... - - J Thorac Oncol - 2010

Manuscript - Secondary - Primary - Respiratory - CALGB-9633

Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901.

Graziano, Stephen L , Herndon, James E , Socinski, Mark A ... - - J Thorac Oncol - 2008

Manuscript - Primary - Primary - Respiratory - CALGB-39901

A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Heist, Rebecca S. , Wang, Xiaofei , Hodgson, Lydia ... - - J Thorac Oncol - 2014

Manuscript - Primary - Primary - Respiratory - CALGB-30704

Randomized multicenter phase II trial evaluating the sequencing of PD-1 inhibition with pembrolizumab (ppembro) and standard platinum-based chemotherapy (chemo) in patients (pts) with metastatic non-small cell lung cancer (NSCLC) AFT-09 (Alliance)

Hensing, Thomas , Wang, Xiaofei , Kozono, David , Dudek, Arkadius ... - ASCO - J. Clin. Oncol. - 2019

Abstract - Primary - Primary - Respiratory - AFT-09

Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).

Jahan, Thierry , Gu, Lin , Kratzke, Robert , Dudek, Arkadiusz ... - - Lung Cancer - 2012

Manuscript - Primary - Primary - Respiratory - CALGB-30107

Biopsy first: Lessons learned from CALGB 140503

Kohman, Leslie J. , Gu, Lin , Altorki, Nasser , Scalzetti, Ernest ... - - J. Thorac. Cardiovasc. Surg. - 2017

Manuscript - Primary - Primary - Respiratory - A081202 , CALGB-140503 , CALGB-580602

Surgeon Error In Predicting Stage I Non-Small Cell Lung Cancer (NSCLC) Is A Major Factor Precluding Randomization In CALGB 140503 (Alliance)

Kohman, Leslie J. , Gu, Lin , Altorki, Nasser , Veit, Linda J. ... - AATS - - 2016

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-140503

Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.

Kratzke, Robert A , Wang, Xiaofei , Wong, Long , Kratzke, Marian G ... - - J Thorac Oncol - 2008

Manuscript - Secondary - Primary - Respiratory - CALGB-159904

Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients.

Le-Rademacher, Jennifer , Lopez, Camden , Wolfe, Eric ... - - J Cachexia Sarcopenia Muscle - 2020

Manuscript - Secondary-not-in-original - Primary - Health Outcome - A151822

A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor risk stage III non-small cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

Lilenbaum, Rogerio , Samuels, Michael , Wang, Xiaofei ... - - J Thorac Oncol - 2015

Manuscript - Primary - Primary - Respiratory - CALGB-30605

Randomized Phase II Trial of Docetaxel Plus Cetuximab or Docetaxel Plus Bortezomib in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2: CALGB 30402

Lilenbaum, Rogerio , Wang, Xiaofei , Gu, Lin , Kirshner, Jeffrey ... - - J Clin Oncol - 2009

Manuscript - Primary - Primary - Respiratory - CALGB-30402

Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial.

Liptay, Michael J , D'amico, Thomas A , Nwogu, Chumy , Demmy, Todd L ... - - J Thorac Oncol - 2009

Manuscript - Primary - Primary - Respiratory - CALGB-140203

Detection of Occult Micrometastases in Patients With Clinical Stage I Non–Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance)

Martin, Linda W. , D’Cunha, Jonathan , Wang, Xiaofei , Herzan, Debra ... - - J. Clin. Oncol - 2016

Manuscript - Primary - Long-Term-Followup - Respiratory - C9761

A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531

Masters, Gregory A. , Wang, Xiaofei , Hodgson, Lydia , Shea, Thomas ... - - Lung Cancer - 2011

Manuscript - Primary - Primary - Respiratory - CALGB-9531

Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.

Miller, Antonius A , Wang, Xiaofei F , Bogart, Jeffrey A ... - - J Thorac Oncol - 2007

Manuscript - Primary - Primary - Respiratory - CALGB-30002

Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).

Miller, Antonius A , Wang, Xiaofei F , Gu, Lin , Hoffman, Philip ... - - J Thorac Oncol - 2008

Manuscript - Primary - Primary - Respiratory - CALGB-30303

VATS Lobectomy Has Better Peri-operative Outcomes than open Lobectomy: CALGB 31001, an Ancillary Analysis of CALGB 140202 (Alliance)

Nwogu, Chukwumere E. , D’Cunha, Jonathan , Pang, Herbert , Gu, Lin ... - - Ann. Thorac. Surg. - 2015

Manuscript - Secondary - Primary - Respiratory - CALGB-31001 , CALGB-140202

Validation of the CALGB and EORTC Prognostic Models for Mesothelioma Based on Multiple CALGB Trials (Alliance)

Pang, Herbert , Hodgson, Lydia , Kratzke, Robert , Crawford, Jeffrey ... - IASLC (WCLC) - J Thoracic Oncol - 2013

Abstract - Secondary-not-in-original - Meta-Analysis - Respiratory - CALGB-8435 , CALGB-8638 , CALGB-8833 , CALGB-8933 , CALGB-9031 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733 , CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807

Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance)

Pang, Herbert , Yan, Kang , Kratzke, Robert , Stinchcombe, Thomas ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint - Meta-Analysis - Respiratory - CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-8435 , CALGB-8638 , CALGB-8833 , CALGB-8933 , CALGB-9031 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733

Adherence and Persistence With Oral Adjuvant Chemotherapy in Older Women With Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104

Partridge, Ann H. , Archer, Laura , Kornblith, Alice B. ... - - J Clin Oncol - 2010

Manuscript - Primary - Primary - Experimental - CALGB-60104 , CALGB-49907

A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734.

Perry, Michael C , Kohman, Leslie J , Bonner, James A , Gu, Lin ... - - Clin Lung Cancer - 2007

Manuscript - Primary - Primary - Respiratory - C9734

Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: Cancer and Leukemia group B (CALGB) 30106, a CALGB-stratified phase II trial.

Ready, Neal , Jänne, Pasi A , Bogart, Jeffrey , Dipetrillo, Thomas ... - - J Thorac Oncol - 2010

Manuscript - Primary - Primary - Respiratory - CALGB-30106 , CALGB-150508

Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC

Ross, Helen J. , Kozono, David , Urbanic, James , Williams, Terence ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint - Trial-Description-Only - Respiratory - AFT-16

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

Rudin, Charles M. , Salgia, Ravi , Wang, Xiaofei , Hodgson, Lydia D. ... - - J. Clin. Oncol. - 2008

Manuscript - Primary - Primary - Respiratory - CALGB-30103

Positive Interaction Between Prophylactic Cranial Irradiation And Maintenance Sunitinib For Untreated Extensive Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis Of CALGB 30504 (Alliance)

Salama, Joseph K. , Gu, Lin , Wang, Xiaofei , Pang, Herbert H. ... - - J Thorac Oncol - 2016

Manuscript - Secondary-not-in-original - Primary - Respiratory - CALGB-30504

Pulmonary toxicity in stage III non-small cell lung cancer patients treated with high dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: A secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105

Salama, Joseph K. , Stinchcombe, Thomas E. , Gu, Lin , Wang, Xiaofei ... - - Int J Radiat Oncol Biol Phys - 2011

Manuscript - Secondary - Primary - Respiratory - CALGB-30105

PCI Survival Improvement for Extensive Stage SCLC Limited to Patients on Maintenance Systemic Therapy: A Secondary Analysis of CALGB 30504 (Alliance)

Salama, Josept K. , Gu, Lin , Wang, Xiaofei , Bogart, Jeffrey ... - IASLC (WCLC) - J Thorac Oncol - 2015

Abstract - Secondary-not-in-original - Primary - Respiratory - CALGB-30504

Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial.

Socinski, Mark A. , Wang, Xiaofei F. , Baggstrom, Maria Quintos ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Respiratory - CALGB-30607

Switch Maintenance with Sunitinib (S) in Advanced Non-Small Cell Lung Cancer (NSCLC): An Alliance (CALGB 30607), Randomized, Placebo-controlled Phase III Trial

Socinski, Mark A. , Wang, Xiaofei F. , Baggstrom, Maria Quintos ... - MSTO - Int. J. Radiat. Oncol. Biol. Phys. - 2014

Abstract - Primary - Primary - Respiratory - CALGB-30607

Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.

Socinski, Mark A , Blackstock, A William , Bogart, Jeffrey A ... - - J. Clin. Oncol. - 2008

Manuscript - Primary - Primary - Respiratory - CALGB-30105

Phase I Study of Accelerated Hypofractionated Radiotherapy with Concurrent Chemotherapy for Stage III Non-Small-Cell Lung Cancer: CALGB 31102 (Alliance)

Urbanic, James J. , Wang, Xiaofei , Bogart, Jeffrey A. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2018

Manuscript - Primary - Primary - Respiratory - CALGB-31102

Phase I Study of Accelerated Hypofractionated Radiotherapy with Concurrent Chemotherapy for Stage III Non-Small-Cell Lung Cancer: CALGB 31102 (Alliance)

Urbanic, James J , Bogart, Jeffrey A , Stinchcombe, Thomas ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2015

Abstract - Primary - Primary - Respiratory - CALGB-31102

Validation of Survival Prognostic Models for Non-Small-Cell Lung Cancer in Stage- and Age-specific Groups

Wang, Xiaofei , Gu, Lin , Zhang, Ying , Sargent, Daniel J. ... - - Lung Cancer - 2015

Manuscript - Secondary-not-in-original - Meta-Analysis - Respiratory - C8834 , C8836 , C8931 , C8932 , C9132 , C9532 , CALGB-140202 , CALGB-140203 , CALGB-30203 , CALGB-30303 , CALGB-30402 , CALGB-30406 , CALGB-30506 , CALGB-30704 , CALGB-39802 , CALGB-39809 , CALGB-39904 , CALGB-9238 , CALGB-9335 , CALGB-9633 , CALGB-9730 , CALGB-9731 , CALGB-9761 , Comprehensive

Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials

Wang, Xiaofei , Wang, Xiaoyi , Hodgson, Lydia , George, Stephen L. ... - - Oncologist - 2017

Manuscript - Secondary-not-in-original - Primary - Respiratory - C8435 , C8638 , C8833 , C8933 , C9031 , CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733 , N0021 , NCCTG-N0623

Comparison of chemotherapy toxicity over time according to age and performance status in patients with advanced non-small cell lung cancer: a toxicity over time analysis of CALGB 9730 (Alliance A151729)

Wong, Melisa L. , Gao, Junheng , Thanarajasingam, Gita ... - SIOG (ISOG) - J Geriatric Oncol - 2018

Abstract - Primary - Primary - Older Adult - CALGB-9730

Expanding beyond maximum grade: Chemotherapy toxicity over time by age and performance status in advanced non-small cell lung cancer in CALGB 9730 (Alliance A151729).

Wong, Melisa L , Gao, Junheng , Thanarajasingam, Gita , Sloan, Jeff A ... - - Oncologist - 2020

Manuscript - Primary - Primary - Older Adult - A151729 , CALGB-9730